Company




Management Team

Seth Green
President and CEO

Mr. Green has over 14 years of experience in business development, finance and strategy. Prior to joining BREONICS, he worked in the Strategy and Operations practice of Deloitte Consulting, serving clients across a variety of industries. He is a graduate of the United States Military Academy at West Point and holds an MBA from the Tuck School of Business at Dartmouth. Prior to his business career, Mr. Green served as an aviation officer in the US Army, leading combat units in Kosovo and Iraq.


Ernest Green, MS
Chairman and Co-Founder

Mr. Green has over 25 years experience in business development, regulatory compliance and industry and government interaction. Prior to BREONICS he served as a Vice President and Director of Facilities and Regulatory Compliance for Alliance Pharmaceutical Corp. (ALLP). Mr. Green also served as Vice President of Business Development and was a Founder and Director of Otisville Biotech, Inc. (OBTI) where he was instrumental in accomplishing a successful IPO for the company in 1984. Before his business career Mr. Green was a microbiologist with New York City Department of Health/ Public Health Research Institute and served as Project Director of a NIH funded program for developing animal models that facilitated the research activities surrounding prion diseases.


Lauren Brasile, Ph. D.
Co-Founder, Executive Vice President and Chief Scientific Officer

Dr. Brasile is a Founder, Executive Vice President and C.S.O. of BREONICS, Inc., and is the inventor of the patents that cover BREONICS’ Exsanguinous Metabolic Support and Immunosuppressive technologies. She has over 30 years experience in transplantation medicine, immunology and organ preservation, with numerous publications in medical journals as well as 3 chapters in textbooks. Since founding BREONICS Dr. Brasile successfully acquired the combined venture, corporate and grant support needed to complete the pre-clinical testing phase necessary to position the technology for the clinic. Most recently she was awarded a 2-year special emphasis grant from the National Institute Allergy Infectious Disease (NIAID) and a 3-year RC3 BRDG-SPAN award from the National Institute of Digestive Disease and Kidney (NIDDK) with a cumulative total of $3.3 Million. As the Director of Research Laboratories for the Department of Surgery at Albany Medical Center her work lead to more than $2-million in research funding from the NIH. While Director, she supervised a staff of 19 research fellows and technologists. She also served as the supervisor of the Transplant Research Laboratories at Ohio State University in the 1970’s with a joint appointment in the Clinical Histocompatability Laboratory supporting the Clinical Transplantation Program. Dr. Brasile received her Ph.D. in the Medical Sciences and Surgery from the University of Maastricht, The Netherlands. She serves on a Special NIH Review Panel for Immunology and is a member of the American Society for Artificial Internal Organs (ASAIO), the American Society of Transplantation (AST) and the International Transplant Congress (ITC). In 1998 Dr. Brasile was honored as “Inventor of the Year” by the Eastern New York State Intellectual Property Law Association.


Bart M. Stubenitsky, M.D., Ph.D.
Vice President Medical Affairs

Dr. Stubenitsky has over 14 years experience in clinical organ transplantation, organ preservation and reconstructive surgery. He received his M.D. from the University of Maastricht in The Netherlands and was involved in the Clinical Renal Transplant Program that was the first in Europe to readdress using the Deceased by Cardiac Donor. Dr. Stubenitsky is a recipient of a Dutch Kidney Foundation Award for his research at the University of Maastricht concerning Warm Organ Preservation that led to his collaboration with Dr. Brasile and BREONICS. Dr. Stubenitsky also completed a fellowship at the University of Toronto, Sick Kids Hospital and is a practicing reconstructive surgeon. He will be directly involved in the EMS clinical development program and is a valuable resource for developing other medical applications for EMS.


Philip M. Glowacki, B.S.
Director of Operations and Process Engineer

Mr. Glowacki is a graduate of Rensselaer Polytechnic Institute with a multidisciplinary background in Chemistry, Biochemistry, Bio-Medical Engineering, and Nanotechnology. Mr. Glowacki has been involved in the development of a variety of novel products. Included are novel polymeric proton exchange membranes for use in hydrogen fuel cells and MEMS (Micro Electo-Mechanical Systems) devices in the form of bio-sensors to monitor metabolic activity. Mr. Glowacki is involved in the day to day activities in support of the clinical development effort.